InsightsStrategy & Competition

Most businesses treat every product line the same way.

By Uttam Dinodia2 min readView this post on LinkedIn

Same investment. Same attention. Same expectations.

That's not a strategy. That's a refusal to make choices.

In the 1970s, GE partnered with McKinsey to solve this exact problem. Managing a portfolio of over 150 business units was becoming impossible using gut feel and politics. They needed a systematic way to decide where to invest and where to walk away.

The result was the GE-McKinsey Matrix - and it changed how corporations think about portfolio strategy:

Not every business unit deserves equal resources. The ones that do depend on two things.

The matrix plots every business unit on two dimensions:

1. Market Attractiveness (external)
How appealing is the industry you're in? This includes market size, growth rate, profitability, competitive intensity, barriers to entry, and pricing trends. It's not just "is the market growing?" It's "is this a market worth fighting for?"

2. Competitive Strength (internal)
How strong is your position in that market? Brand, market share, cost structure, customer loyalty, distribution strength, innovation track record, management quality. It's not just "are we present?" It's "can we win?"

The combination creates a 3x3 grid with three clear zones:

  • Invest - High attractiveness, strong position. Pour resources here.
  • Hold - Medium on both. Maintain, don't over-invest.
  • Divest - Low attractiveness, weak position. Exit or harvest.

The brilliance isn't the grid. It's the discipline it forces.

That's the real value of portfolio thinking:

It doesn't tell you what to do. It shows you what you're avoiding.

If every product in your portfolio gets equal attention, you don't have a strategy. You have a to-do list.

What would your business look like if you had the courage to focus only on where you can actually win?

♻️ Repost if you believe strategic focus beats spreading resources thin.

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.